Adolescent schizophrenia is a severe, chronic mental health disorder that affects a person's thinking, emotions, and behavior. It is a form of schizophrenia that manifests during adolescence, typically between the ages of 13 and 18, though it can sometimes occur earlier. This period is particularly challenging because it coincides with significant developmental changes both physically and psychologically.
Patients are the experts in their condition and advocacy groups provide a platform for patient voices. Working directly with these communities is the key to pushing research forward in an inclusive way.
By educating communities about schizophrenia, we can dismantle stigma, advocate for accessible resources, and create a supportive environment for affected adolescents to thrive, fostering a more compassionate and inclusive society. At Leapcure, we are committed to providing resources and support for individuals and families navigating the challenges of adolescent schizophrenia.
Read more...
We’re ready to keep forming links between our Advocacy friends and Pharma partners, so these fruitful relationships continue to evolve beyond the study-to-study view.
Read more...
The ever-growing investment in advocacy doesn’t appear to be slowing down, and research is certainly seeing the benefits. Which at the end of the day, means better patient care and more options for patients.
Read more...
We’ve committed to having 500,000 conversations in the next three years, to equip ourselves and our Pharma partners with the insights needed to increase predictability.
Read more...